Ideaya Biosciences Inc (NASDAQ: IDYA) is -10.91% lower on its value in year-to-date trading and has touched a low of $23.41 and a high of $47.74 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IDYA stock was last observed hovering at around $30.73 in the last trading session, with the day’s gains setting it 0.97%.
Currently trading at $31.70, the stock is -8.35% and -15.51% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.83 million and changing 3.16% at the moment leaves the stock -20.34% off its SMA200. IDYA registered 22.73% gain for a year compared to 6-month loss of -24.79%. The firm has a 50-day simple moving average (SMA 50) of $37.2964 and a 200-day simple moving average (SMA200) of $39.780174.
The stock witnessed a -16.82% gain in the last 1 month and extending the period to 3 months gives it a -4.78%, and is 4.38% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.38% over the week and 4.90% over the month.
Ideaya Biosciences Inc (IDYA) has around 124 employees, a market worth around $2.68B and $11.96M in sales. Profit margin for the company is -1285.34%. Distance from 52-week low is 35.41% and -33.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-16.48%).
The EPS is expected to shrink by -28.85% this year
293.0 institutions hold shares in Ideaya Biosciences Inc (IDYA), with institutional investors hold 103.25% of the company’s shares. The shares outstanding are 84.48M, and float is at 76.56M with Short Float at 15.29%. Institutions hold 102.16% of the Float.
The top institutional shareholder in the company is FMR LLC with over 11.27 million shares valued at $395.69 million. The investor’s holdings represent 14.4557 of the IDYA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 6.81 million shares valued at $239.02 million to account for 8.7321 of the shares outstanding. The other top investors are FEDERATED HERMES, INC. which holds 4.86 million shares representing 6.2283 and valued at over $170.49 million, while VANGUARD GROUP INC holds 5.4728 of the shares totaling 4.27 million with a market value of $149.81 million.
Ideaya Biosciences Inc (IDYA) Insider Activity
Ideaya Biosciences Inc disclosed in a document filed with the SEC on May 29 ’24 that WHITE MICHAEL ANTHONY (Chief Scientific Officer) sold a total of 28,500 shares of the company’s common stock. The trade occurred on May 29 ’24 and was made at $36.24 per share for $1.03 million. Following the transaction, the insider now directly holds 0.0 shares of the IDYA stock.
Still, SEC filings show that on May 15 ’24, Hata Yujiro S (President and CEO) disposed off 83,856 shares at an average price of $42.90 for $3.6 million. The insider now directly holds 677,887 shares of Ideaya Biosciences Inc (IDYA).
